Free tool
FAERS Monitor: Primatene Mist
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205920 or its brand name (Primatene Mist, Epinephrine). Reports on generic versions are filed under their own applications.
Reports
496
Serious
273
55% of reports
Hospitalization
53
Death reported
21
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective94
- dyspnoea60
- asthma33
- chest pain31
- throat irritation29
- burning sensation28
- cough25
- dizziness23
- heart rate increased19
- headache17
- tremor16
- condition aggravated15
- pharmaceutical product complaint15
- incorrect dose administered14
- palpitations14
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 17 |
| 2005 | 11 |
| 2006 | 42 |
| 2007 | 17 |
| 2008 | 112 |
| 2009 | 14 |
| 2010 | 13 |
| 2011 | 18 |
| 2012 | 16 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 20 |
| 2020 | 34 |
| 2021 | 37 |
| 2022 | 31 |
| 2023 | 31 |
| 2024 | 15 |
| 2025 | 29 |
| 2026 | 27 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,663 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| throat irritationSignal | 29 | 27.4 | 19.3 | 713 |
| pharmaceutical product complaintSignal | 15 | 24.5 | 14.9 | 315 |
| burning sensationSignal | 28 | 16.9 | 11.8 | 405 |
| asthmaSignal | 33 | 12.4 | 8.9 | 336 |
| heart rate increasedSignal | 19 | 8.1 | 5.2 | 112 |
| chest painSignal | 31 | 7.1 | 5.0 | 158 |
| palpitationsSignal | 14 | 5.1 | 3.0 | 42 |
| dyspnoeaSignal | 60 | 4.5 | 3.5 | 164 |
| tremorSignal | 16 | 4.1 | 2.5 | 35 |
| coughSignal | 25 | 3.8 | 2.6 | 49 |
| drug ineffectiveSignal | 94 | 3.0 | 2.5 | 134 |
| incorrect dose administeredSignal | 14 | 2.6 | 1.6 | 12 |
| condition aggravatedSignal | 15 | 2.1 | 1.3 | 8 |
| dizziness | 23 | 2.0 | 1.3 | 10 |
| headache | 17 | 1.1 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.